Skip to main content
. 2011 Nov 11;6(11):e27265. doi: 10.1371/journal.pone.0027265

Figure 3. Effect of pre- and post-treatment with Ashwagandha i-Extract on scopolamine-induced changes in BDNF and GFAP expression in mice brain.

Figure 3

Effects of pre, post and per se treatment of i-Extract (200 mg/Kg BW) on mRNA expression (A) and protein (B) levels of BDNF and GFAP in the mouse cerebrum. Data was quantitated and is presented as percent relative units. Lane 1-Control, Lane 2-scopolamine, Lane 3-post-treatment with i-Extract, Lane 4-per se treatment of i-Extract, Lane 5-Pre-treatment with i-Extract. *denotes significant differences (P<0.05) between the SC group and i-Extract group. #denotes significant differences (P<0.05) between Control and SC group.